text:  That's perhaps good in a way, right? Because these folks know what's coming for them. Maybe they're most excited. They have positive experiences. But of course, in principle, this isn't the target population for an FDA approval, right? And so I think we need to understand, we need to recruit broader sets of participants. We need to record who they are. You know, how many previous PTSD episodes have you had or how long has your trauma been lasting? But also